NYSE
TAK
Takeda Pharmaceutical Company Limited
- Health Care
- Japan
- Listed 2018
- 1 day
- +1.8%
- 1 month
- +0.4%
- 1 year
- +19.3%
$17.02 · Mkt cap $53.8B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
NYSE
Takeda Pharmaceutical Company Limited
$17.02 · Mkt cap $53.8B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Takeda Pharmaceutical Company Limited trades under the ticker TAK on NYSE, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $53.8B. The last closing price was $17.02, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +19.3%, and +0.4% over the past month. Returns are price returns and exclude dividends.
This page exists because TAK is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.